Myopia Today

An estimated 5 billion people or half of the global population could be myopic in 20501. The incidence of myopia is predicted to further rise, as factors associated with a greater likelihood of myopia increase1. These factors include near-work activities, less time spent outdoors, and high value placed on education.

To reduce the severity of this worldwide problem, it’s especially important to offer myopia management solutions early in life, protecting the eyesight of future visionaries. As a non-invasive and effective myopia management solution, MiYOSMART helps parents and children ensure future vision health.


MiYOSMART with Defocus Incorporated Multiple Segments (D.I.M.S.) Technology is a single vision corrective lens with a convex surface that is comprised of hundreds of small segments, each providing myopic defocus. This lens structure makes it possible to simultaneously retard the growth of the eyeball and provide clear vision. To effectively control myopia progression, myopic defocus has to be experienced by the wearer constantly, even during eye movement.

Find out more on how you can address concerns on myopia progression with MiYOSMART by visiting us at any of our Zoff Outlets!

*MiYOSMART is not available at Zoff ITE College Central

MiYOSMART is Clinically Proven!

The results of a two-year clinical trial concluded that children wearing MiYOSMART lens had myopic progression reduced by an average of 59%* and axial elongation of eye decreased by an average of 60%* compared to children wearing conventional single vision lens.

MiYOSMART six-year follow-up clinical study, the longest study conducted on a myopia management spectacle lens ever, proved that the MiYOSMART spectacle lens myopia control effect is sustained over time^ for children wearing the lens. It also confirmed that children who stop wearing MiYOSMART spectacle lens show no rebound effects^ when compared to the initial myopia rates of progression during the two-year randomised control trial or with the general population

Why Choose MiYOSMART?


MiYOSMART lenses with D.I.M.S. Technology has proven clinical track record of slowing down myopia progression in children by an average of 60%


Spectacle myopia management method makes it possible to manage your child’s myopia in a safe and non-invasive way.
Thin & Light
UV Protection
Impact resistant


Wearing of spectacles is relatively easy for your child to comply with and care for.
Low maintenance
Water repellent
Easy to wipe

MiYOSMART Sun, Photochromic Myopia Management spectacle lenses

Research studies have shown that spending time outdoors may slow down myopia progression in children,2,3 and as such it is the most common recommended behavioural myopia management solution4. However, children are more are more susceptible to eye damage from UV light than adults, as the majority of lifetime sun exposure occurs under the age of 215-7.

MiYOSMART Sun spectacle lenses adopted the award-winning D.I.M.S. Technology to correct myopic refractive error and slow down myopia progression for effective and non-invasive myopia management8-12. MiYOSMART Sun spectacle lenses also protect from intense sunlight, providing eye comfort, and thus encouraging children to wear myopia management spectacle lenses outdoors5,13-15.

Taking care of eyesight. Wearers should:

1. Spend more time outdoors, minimum 2 hours a day.

2. Take breaks from long intensive screen time or near-work.

3. Take note of ergonomics,such as proper lighting, posture, keeping the recommended working distance are very important to keep your eyes healthy while doing the near-work.

4. Get regular eye check-ups to ensure that myopia or other vision problems are detected and treated early, reducing the worsening of vision, myopia progression and potential complications of high myopia.


1Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042.

2Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019;16(14):2595.

3 Jonas JB, Ang M, Cho P, et al. IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci. 2021;62(5):6.

4 WSPOS. Myopia Survey Data. November 2022. Presented as part of WSPOS Symposium: Comprehensive Update on Myopia Management.19-20 November 2022. Available from: (Last accessed: 20/02/2023)

5 WSPOS. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at: (Last accessed 20/02/2023)

6 Prevent Blindness. Children’s Eyes are More Susceptible to Long-Term Damage from UV Rays. 2011. Available at: (Last accessed 20/02/2023)

7 Artigas JM, Felipe A, Navea A, Fandiño A, Artigas C. Spectral transmission of the human crystalline lens in adult and elderly persons: color and total transmission of visible light. Invest Ophthalmol Vis Sci. 2012;53(7):4076-4084.

8 Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363-368.

9HOYA data on file. PSF test on MiYOSMART clear and sun spectacle lenses. 06/2022

10Winners of the exhibition’s grand prix. Inventions Geneva. 2019. Available from: (Last accessed 20/02/2023)

11Winners 2020. Silmo Paris. 2020. (Last accessed 20/02/2023).

13Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.

14Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574.

15Wu PC, Kuo HK. Effect of photochromic spectacles on visual symptoms and contrast sensitivity of myopic schoolchildren treated with low dose concentration atropine. Invest Ophthalmol Vis Sci. 2016;57:2484.

*Myopia progression (SER) by 59% and axial elongation (AL) decreased by 60% compared with those wearing SV lenses. Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019.